BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28863137)

  • 1. Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA.
    Sanz DJ; Hollywood JA; Scallan MF; Harrison PT
    PLoS One; 2017; 12(9):e0184009. PubMed ID: 28863137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of gene repair tracts from Cas9/gRNA double-stranded breaks in the human CFTR gene.
    Hollywood JA; Lee CM; Scallan MF; Harrison PT
    Sci Rep; 2016 Aug; 6():32230. PubMed ID: 27557525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of CFTR intronic variants identified during cystic fibrosis population screening by a minigene splicing assay.
    Giorgi G; Casarin A; Trevisson E; Donà M; Cassina M; Graziano C; Picci L; Clementi M; Salviati L
    Clin Chem Lab Med; 2015 Oct; 53(11):1719-23. PubMed ID: 25781545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and functional correction of a deep intronic splicing mutation in
    Walker AJ; Graham C; Greenwood M; Woodall M; Maeshima R; O'Hara-Wright M; Sanz DJ; Guerrini I; Aldossary AM; O'Callaghan C; Baines DL; Harrison PT; Hart SL
    Mol Ther Methods Clin Dev; 2023 Dec; 31():101140. PubMed ID: 38027060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine characterization of the recurrent c.1584+18672A>G deep-intronic mutation in the cystic fibrosis transmembrane conductance regulator gene.
    Costantino L; Rusconi D; Soldà G; Seia M; Paracchini V; Porcaro L; Asselta R; Colombo C; Duga S
    Am J Respir Cell Mol Biol; 2013 May; 48(5):619-25. PubMed ID: 23349053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a disease-associated mutation affecting a putative splicing regulatory element in intron 6b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
    Faà V; Incani F; Meloni A; Corda D; Masala M; Baffico AM; Seia M; Cao A; Rosatelli MC
    J Biol Chem; 2009 Oct; 284(44):30024-31. PubMed ID: 19759008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells.
    Michaels WE; Bridges RJ; Hastings ML
    Nucleic Acids Res; 2020 Jul; 48(13):7454-7467. PubMed ID: 32520327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital absence of the vas deferens and their association with cystic fibrosis genetic modifiers.
    Sharma H; Mavuduru RS; Singh SK; Prasad R
    Mol Hum Reprod; 2014 Sep; 20(9):827-35. PubMed ID: 24958810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Cas9 and Cas12a CRISPR editing methods to correct the W1282X-CFTR mutation.
    Santos L; Mention K; Cavusoglu-Doran K; Sanz DJ; Bacalhau M; Lopes-Pacheco M; Harrison PT; Farinha CM
    J Cyst Fibros; 2022 Jan; 21(1):181-187. PubMed ID: 34103250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exon-skipping antisense oligonucleotides for cystic fibrosis therapy.
    Kim YJ; Sivetz N; Layne J; Voss DM; Yang L; Zhang Q; Krainer AR
    Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35017301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating REPAIRv2 as a Tool to Edit
    Melfi R; Cancemi P; Chiavetta R; Barra V; Lentini L; Di Leonardo A
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32640650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing.
    Zuccato E; Buratti E; Stuani C; Baralle FE; Pagani F
    J Biol Chem; 2004 Apr; 279(17):16980-8. PubMed ID: 14966131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis patients with the 3272-26A-->G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane.
    Beck S; Penque D; Garcia S; Gomes A; Farinha C; Mata L; Gulbenkian S; Gil-Ferreira K; Duarte A; Pacheco P; Barreto C; Lopes B; Cavaco J; Lavinha J; Amaral MD
    Hum Mutat; 1999; 14(2):133-44. PubMed ID: 10425036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides.
    Igreja S; Clarke LA; Botelho HM; Marques L; Amaral MD
    Hum Mutat; 2016 Feb; 37(2):209-15. PubMed ID: 26553470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element.
    Pagani F; Buratti E; Stuani C; Romano M; Zuccato E; Niksic M; Giglio L; Faraguna D; Baralle FE
    J Biol Chem; 2000 Jul; 275(28):21041-7. PubMed ID: 10766763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA-based detection of rare CFTR mutations improves genetic diagnosis of cystic fibrosis in populations with high genetic heterogeneity.
    Felício V; Ramalho AS; Igreja S; Amaral MD
    Clin Genet; 2017 Mar; 91(3):476-481. PubMed ID: 27174726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional restoration of a CFTR splicing mutation through RNA delivery of CRISPR adenine base editor.
    Amistadi S; Maule G; Ciciani M; Ensinck MM; De Keersmaecker L; Ramalho AS; Guidone D; Buccirossi M; Galietta LJV; Carlon MS; Cereseto A
    Mol Ther; 2023 Jun; 31(6):1647-1660. PubMed ID: 36895161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing.
    Maule G; Casini A; Montagna C; Ramalho AS; De Boeck K; Debyser Z; Carlon MS; Petris G; Cereseto A
    Nat Commun; 2019 Aug; 10(1):3556. PubMed ID: 31391465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P.F508del editing in cells from cystic fibrosis patients.
    Smirnikhina SA; Kondrateva EV; Adilgereeva EP; Anuchina AA; Zaynitdinova MI; Slesarenko YS; Ershova AS; Ustinov KD; Yasinovsky MI; Amelina EL; Voronina ES; Yakushina VD; Tabakov VY; Lavrov AV
    PLoS One; 2020; 15(11):e0242094. PubMed ID: 33175893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open reading frame correction using splice-switching antisense oligonucleotides for the treatment of cystic fibrosis.
    Michaels WE; Pena-Rasgado C; Kotaria R; Bridges RJ; Hastings ML
    Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35017302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.